Literature DB >> 28327903

Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation.

J Schrader1, F O Henes2, D Perez3, S Burdak-Rothkamm4, A Stein5, J R Izbicki3, A W Lohse1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28327903     DOI： 10.1093/annonc/mdx007

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

Review 1.  Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.

Authors:  R M Ruggeri; E Benevento; F De Cicco; B Fazzalari; E Guadagno; I Hasballa; M G Tarsitano; A M Isidori; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2022-08-30       Impact factor: 5.467

2.  An autophagy-related model of 4 key genes for predicting prognosis of patients with laryngeal cancer.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Hong-Bing Liu
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.